inteneded for treatment of - active rheumatoid arthritis in adult patients research hub

An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers under fasting conditions.

This study is testing a new version of a medicine for serious health problems like rheumatoid arthritis, psoriasis, and Crohn's disease. We want to see if the new medicine works the same way as an existing one. Healthy adult men are taking part to help us find out.